Study of GSK2132231A antigen-specific cancer immunotherapeutic in patients with inoperable metastatic cutaneous melanoma.

Journal of Drugs in DermatologyVol. 9 Nbr. 10, October 2010

Linked as:

Summary


SKIN CANCER - Brief article

See the full content of this document

Extract


Study of GSK2132231A antigen-specific cancer immunotherapeutic in patients with inoperable metastatic cutaneous melanoma.

Sponsored by GlaxoSmithKline. The clin...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company